Search Results - "Tran, Huyen A."

Refine Results
  1. 1

    New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism by Tran, Huyen A, Gibbs, Harry, Merriman, Eileen, Curnow, Jennifer L, Young, Laura, Bennett, Ashwini, Tan, Chee Wee, Chunilal, Sanjeev D, Ward, Chris M, Baker, Ross, Nandurkar, Harshal

    Published in Medical journal of Australia (01-03-2019)
    “…Introduction Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most common cardiovascular disease…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Venous anomalies and thromboembolism by Dix, Caroline, Clements, Warren, Gibbs, Harry, So, Joanne, A Tran, Huyen, D McFadyen, James

    Published in Thrombosis journal (20-04-2023)
    “…Patients with venous anomalies are at increased risk of developing venous thromboembolism (VTE) and subsequent complications, but they are often…”
    Get full text
    Journal Article
  4. 4

    Tranexamic acid modulates the immune response and reduces postsurgical infection rates by Draxler, Dominik F., Yep, Kah, Hanafi, Gryselda, Winton, Anoushka, Daglas, Maria, Ho, Heidi, Sashindranath, Maithili, Wutzlhofer, Lisa M., Forbes, Andrew, Goncalves, Isaac, Tran, Huyen A., Wallace, Sophia, Plebanski, Magdalena, Myles, Paul S., Medcalf, Robert L.

    Published in Blood advances (28-05-2019)
    “…Tranexamic acid (TXA) is an antifibrinolytic agent that blocks plasmin formation. Because plasmin is known to promote inflammatory and immunosuppressive…”
    Get full text
    Journal Article
  5. 5

    Venous Thromboembolism and Estrogen-Containing Gender-Affirming Hormone Therapy by Dix, Caroline, Moloney, Mollie, Tran, Huyen A, McFadyen, James D

    Published in Thrombosis and haemostasis (01-05-2024)
    “…Gender-affirming therapy involves the use of hormones to develop the physical characteristics of the identified gender and suppressing endogenous sex hormone…”
    Get more information
    Journal Article
  6. 6

    Exploring the effects of Factor Xa inhibitors on thrombin generation in people with haemophilia by Dix, Caroline, McFadyen, James D., Tran, Huyen A.

    Published in Thrombosis research (01-05-2024)
    “…Optimal management of cardiovascular disease (CVD) in people with haemophilia (PWH) is a growing issue, given the continuing improvement in life expectancy…”
    Get full text
    Journal Article
  7. 7

    Congenital fibrinogen disorders: Strengthening genotype–phenotype correlations through novel genetic diagnostic tools by Ramanan, Radha, McFadyen, James D., Perkins, Andrew C., Tran, Huyen A.

    Published in British journal of haematology (01-11-2023)
    “…Congenital fibrinogen disorders or CFDs are heterogenous, both in clinical manifestation and array of culprit molecular lesions. Correlations between phenotype…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Mutational landscape, inhibitor development, and health-care burden in non-severe haemophilia A: A single-centre Australian experience by Ramanan, Radha, Evans, Natalie, Kaplan, Zane, McFadyen, James D, Tran, Huyen A

    “…To characterise non-severe haemophilia A (HA) patients enrolled on the Australian Bleeding Disorders Registry (ABDR) treated through a state-wide Haemophilia…”
    Get full text
    Journal Article
  11. 11

    Osteoporosis management and falls prevention in patients with haemophilia: Review of haemophilia guidelines by Petkovic, Madison J., Tran, Huyen A, Ebeling, Peter R., Zengin, Ayse

    “…Introduction Patients with haemophilia (PWH) have a high prevalence of osteoporosis, falls and fractures at all ages. The role of haemophilia itself may…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    An update of consensus guidelines for warfarin reversal by Tran, Huyen A, Chunilal, Sanjeev D, Harper, Paul L, Tran, Huy, Wood, Erica M, Gallus, Alex S

    Published in Medical journal of Australia (04-03-2013)
    “…For most warfarin indications, the target international normalised ratio (INR) is 2.0–3.0 (venous thromboembolism and single mechanical heart valve excluding…”
    Get full text
    Journal Article
  15. 15

    Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem by Clarke, Lisa, Brighton, Timothy, Chunilal, Sanjeev D., Lee, Christine S.M., Passam, Freda, Curnow, Jennifer, Chen, Vivien M., Tran, Huyen A.

    Published in Vaccine (11-05-2023)
    “…•VITT is a complication ChAdOx1 nCoV19 vaccination (AZD1222) vaccination.•Clinicopathological features suggest a less severe phenotype when compared to…”
    Get full text
    Journal Article
  16. 16

    Approval of the first protease-activated receptor antagonist: Rationale, development, significance, and considerations of a novel anti-platelet agent by French, Shauna L, Arthur, Jane F, Tran, Huyen A, Hamilton, Justin R

    Published in Blood reviews (01-05-2015)
    “…Abstract Twenty-three years after the discovery of the first thrombin receptor, now known as protease-activated receptor 1 (PAR1), the first drug targeting…”
    Get full text
    Journal Article
  17. 17
  18. 18

    The utility of the Wells clinical prediction model and ventilation-perfusion scanning for pulmonary embolism diagnosis in pregnancy by Cutts, Briony A, Tran, Huyen A, Merriman, Eileen, Nandurkar, Dee, Soo, Gil, DasGupta, Dhruba, Prassannan, Nita, Hunt, Beverley J

    Published in Blood coagulation & fibrinolysis (01-06-2014)
    “…Pulmonary embolism is one of the leading causes of mortality in pregnancy in the Western world. No clinical prediction models have been validated in pregnancy…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Overcoming aspirin treatment failure in diabetes by Linden, Matthew D., Tran, Huyen A.

    “…People with diabetes have an increased risk of life-threatening cardiovascular disease compared to the general population. Furthermore, people with diabetes…”
    Get full text
    Journal Article